Aug 17, 2022

Philips partners in world-class medical training centre in Gold Coast Health precinct

GOLD COAST, AUSTRALIA – Global healthcare technology leader Philips will partner in a cutting-edge research and training centre in the Gold Coast Health and Knowledge Precinct (GCHKP), where its latest image-guided therapy technology will support training specialist physicians from across the Asia-Pacific and pioneer new precision approaches in a wide range of clinical areas – from cardiovascular disease to stroke, cancer, and spine conditions.

Led by interventional neuroradiologists Dr. Hal Rice and Dr. Laetitia de Villiers, who deliver the latest innovative treatments for stroke and brain aneurysms at Gold Coast University Hospital (GCUH), the facility will showcase Philips’ interventional solutions and trial new technologies such as artificial intelligence (AI), robotics and novel 3D printed anatomical models.

Building on a strong track-record of conducting clinical trials and delivering specialised training at GCUH over the last decade, Dr. Rice said: “this dedicated facility will have the latest equipment and space to accommodate larger groups, without the constraints of prioritising patient care within a busy hospital environment.”

“Importantly we’ll be able to expand our research and development (R&D) in the neurovascular field, while broadening training in other surgical specialties, widely utilising 3D printed models to revolutionise training and looking to a future where AI and robotics will enable remote procedures, virtually anywhere in the world.”

it is incredible to have Philips’ support as our key technology partner and to also be able to bring other leading medical device companies to our facility to join forces in R&D.”

Dr. Hal Rice

Gold Coast University Hospital

Philips will equip the centre with their Azurion biplane system, a leading platform for interventional procedures, favoured for its intuitive, seamless approach that enables clinicians to focus on treating the patient. The latest version of Azurion takes a further leap in integrating essential lab systems and tools in one platform.

Interventional radiologist and Philips’ Chief Medical Officer for Image Guided Therapy Dr. Atul Gupta, said that the global reputation of Dr. Rice and Dr. de Villiers was key to the decision to collaborate in the centre.

“Optimising the workflow across the entire care pathway offers the best chance of improving outcomes for patients with neurological conditions such as stroke and cerebral aneurysms,” said Dr. Gupta.

We are very excited to collaborate with leading physicians and contribute to innovative developments in diagnosis and treatment. Together we can further optimise the clinical workflow, remove the hurdles to faster, more decisive treatment, and improve neurologic outcomes.”

Dr. Atul Gupta

Chief Medical Officer Philips Image Guided Therapy

The GCHKP location represents an added opportunity to create collaborations with Griffith University researchers, other clinicians and industry partners.

Dr. Rice and Dr. de Villiers have significant pulling power, having hosted the 2015 world congress in their field, which attracted more than 1200 delegates, and having undertaken world-first-in-human neurovascular trials, including four device trials in 2021, and numerous first-in-Australia trials. In 2020, Dr. Rice performed the world’s first robotic neurovascular stroke clot removal, and the team has the largest caseload globally for robotic brain aneurysm repairs.

Dr. de Villiers said the new centre would be equipped to enable live links to theatre suites for training doctors to be able to review and then replicate complex procedures.

“They will be able to practice on exact 3D printed replica models of the brain blood vessels of patients whose procedures they have just watched us undertake, utilising the state-of-the-art Philips image guidance system,” said Dr. de Villiers. “They will also be able to rehearse their own patient cases on personalised patient models that accurately simulate the feeling of pulsing blood, that we can 3D print in advance of training, and we can guide them through these difficult procedures.”

The new centre, which will also be equipped with high-quality audiovisual and high-speed data links, has been enabled through a substantial fit-out of an existing GCHKP building in the Lumina commercial hub, supported by NorthWest Healthcare Properties, ahead of the proposed development of their ultimate facility – ‘RDX Lumina’.

The pilot facility, within a legacy building from the Gold Coast 2018 Commonwealth Games, will move into an expanded space in RDX Lumina, a world-class, eight-storey building with planned 6 Star Green Star rating and a proposed bridge link into Gold Coast Private Hospital, planned by NorthWest, Australia’s largest owner, manager and developer of healthcare real estate.

NorthWest Vice President - Leasing, Georgie Huxley, said of the development: “NorthWest specialises in the development and ownership of market-leading health and life sciences properties and precincts, where we combine complementary facilities and the best medical experts in the field to create a hub of the highest quality healthcare offering possible. RDX Lumina is a great example of the intersect between research, innovation, healthcare and clinical training, led by the involvement of industry leaders Dr. Rice and Dr. de Villiers.

We are proud to be delivering this innovative training facility via our team of Australia’s healthcare real estate experts, as the largest specialist healthcare real estate operator in the country by a considerable margin, leading the way in building design and delivery for this eminent site.”

About Gold Coast Health and Knowledge Precinct

IN ASIA-PACIFIC’S EMERGING HEALTH AND INNOVATION HUB, OUR PEOPLE TRANSFORM LIVES THROUGH HEALTHCARE INNOVATION, NEW KNOWLEDGE AND NEXT-GENERATION TECHNOLOGIES. BACKED BY $5 BILLION INVESTED IN HEALTH, EDUCATION, TRANSPORT AND RESIDENTIAL INFRASTRUCTURE, OUR 200-HECTARE PRECINCT IS ANCHORED BY TWO HOSPITALS AND GRIFFITH UNIVERSITY, AND IS HOME TO 15,000 WORKERS, INCLUDING 1,000 RESEARCHERS, 20,000 STUDENTS AND 50 SMES AND TECH COMPANIES.

Click here to read more Click here to read less

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2021 sales of EUR 17.2 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found on our news center.

Click here to read more Click here to read less

About NorthWest Healthcare Properties Management in Australia and New Zealand

NorthWest Healthcare Properties Management (“NorthWest) is the largest healthcare real estate owner, manager and developer (for long term ownership) in Australia and New Zealand (“A/NZ”), with ~A$6.6 billion of assets under management (“AUM”) in A/NZ. NorthWest A/NZ is on a strong growth trajectory, with AUM in A/NZ growing 29.5% in the last year alone. In addition to its AUM in A/NZ, NorthWest’s development pipeline is currently ~A$3.2 billion, with 12 projects presently under construction and committed. NorthWest specialises in market-leading hospital, health, and life sciences properties and precincts. As a capital provider, partner and landlord to the health sector the A/NZ team of ~60 staff are solely dedicated to the investment in and development of healthcare real estate assets in A/NZ, having done so for the last 25 years.

NorthWest A/NZ is a wholly owned subsidiary of the Toronto-listed NorthWest Healthcare Properties REIT (TSX:NWH.UN), an unincorporated, open-ended real estate investment trust. The REIT provides investors with access to a portfolio of high-quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of ~220 income-producing properties located throughout major markets in Canada, the United States, Brazil, Germany, the Netherlands, the United Kingdom, Australia and New Zealand. NorthWest’s A/NZ site can be accessed here: https://www.nwhproperties.com.au/

Click here to read more Click here to read less